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Phylogenetic analysis of CC5 strain WGS showed great variability ( Figure 1A) , with isolates from 1 3 6 various countries dispersed throughout the tree. A strong geographic signal however was apparent 1 3 7 amongst the isolates from Sri Lanka, with all but three CC5-PVL-positive MRSA isolates clustering 1 3 8 into a single clade, herein dubbed the "Sri Lankan clade" (Figure 1B) . Isolates from the United 1 3 9
Kingdom (13) and Australia (1) were also found in the Sri Lankan clade, including those from 1 4 0 patients with no known links to Sri Lanka. Within the clade, the isolates were identified as multilocus 1 4 1 sequence type (ST) 5, harboured the enterotoxin gene cluster (egc), and for the MRSA isolates 1 4 2 harboured the SCCmec IVc staphylococcal cassette chromosome mec subtype. All but one isolate 1 4 3 encoded the plasmid-borne enterotoxin genes (sed, sej and ser). Greater variability was apparent for 1 4 4 other traits including the sep enterotoxin gene. Genes encoding resistance to erythromycin (erm(C)) 1 4 5 or tetracycline (tet(K)) were variably detected highlighting the dynamic loss/acquisition of mobile 1 4 6 genetic elements within the clone. Similarly, a chromosomal mutation associated with quinolone 1 4 7 resistance (grlA 80:S-F) was noted sporadically. A single isolate from a UK patient with links to Sri 1 4 8
Lanka was identified as being genotypically multi-drug resistant, encoding blaZ, mecA, erm(C), 1 4 9 tet(K), aphA3 and sat4 genes. Bayesian phylogenetic reconstruction using BEAST (data not shown) 1 5 0 failed to provide significant temporal signal for predicting evolutionary rate and time to common 1 5 1 ancestor. 1 5 2 1 5 3 Discussion 1 5 4
Particular lineages of MRSA are frequently associated with various geographical origins e.g. 1 5 5 ST8/USA300 (North America); ST93 (Australia); ST80 (North Africa); ST30 (South-West Pacific) 1 5 6 (David and Daum, 2010; Chua et al., 2011) . Prior to the current study, CC5 PVL-positive MRSA has 1 5 7 been reported in many countries world-wide (Monecke et al., 2011); however, their origin(s) are 1 5 8
unclear. A recent phylogenomic study of CC5-MRSA isolates from the Western Hemisphere showed 1 5 9 high diversity, even among strains that shared the same SCCmec type circulating in the same country 1 6 0 (Challagundla et al., 2018) . Very few whole genome sequences from CC5-MRSA isolates from Asian 1 6 1 countries are currently available. 1 6 2 1 6 3
Herein, in most instances, phylogenetic analysis of CC5 PVL-positive MRSA from four continents 1 6 4
showed clustering according to their geographic location, suggesting they have arisen independently 1 6 5 in different parts of world following the acquisition of PVL phage and/or different SCCmec elements. 1 6 6
Our data provide evidence of a successful ST5-PVL-positive MRSA-IVc clone in Sri Lanka with 1 6 7 multiple incursions to distant geographical regions. Thirteen isolates from England were interspersed 1 6 8 within the Sri Lankan clade; ten with known links to Sri Lanka. One isolate from Australia also 1 6 9 clustered within the Sri Lankan clade, however a link to Sri Lanka could not be determined. Whilst in 1 7 0 our study all Sri Lankan isolates were collected systematically without undue bias, it is important to 1 7 1 acknowledge that the number of isolates is small and that they were collected from a single centre 1 7 2 over a relatively short timeframe. However, the UK CC5 PVL-positive MRSA isolates in the Sri 1 7 3
Lankan clade, including those with known links to Sri Lanka, were collected over the course of a 1 7 4 decade prior to our study. This suggests that wider circulation of this PVL-positive ST5-MRSA-IVc 1 7 5 clone is likely in Sri Lanka and that our newly collected samples do not simply represent a clonal 1 7 6 outbreak in Anuradhapura Teaching Hospital. A larger study of isolates from other parts of Sri Lanka 1 7 7 and globally is required to help elucidate the origins and dissemination of PVL-positive MRSA 1 7 8 belonging to the CC5 lineage. The ST5-PVL-positive MRSA-IVc clone identified was also 1 7 9 responsible for both CO-and HO-infections, emphasising the increasingly blurred lines between 1 8 0 community and hospital-associated infections reported (Skov and Jensen, 2009). 1 8 1 1 8 2
In conclusion, we have presented the most detailed genomic analysis of MRSA isolated in Sri Lanka 1 8 3 to date and have demonstrated, at least in the hospital and catchment area studied, that clinical MRSA 1 8 4 infections in Sri Lanka are dominated by a PVL-positive ST5-MRSA-IVc clone. We have also shown 1 8 5 the clone can be found in English patients with a history of travel to Sri Lanka. Further work is 1 8 6 required to determine the prevalence of carriage and infection associated with PVL-positive ST5-1 8 7
MRSA-IVc in Sri Lanka, and the dynamics of transmission in and out of hospital, and whether these 1 8 8
findings are replicated on a national scale. 1 8 9 1 9 0
Conflict of interest 1 9 1
The authors declare that the research was conducted in the absence of any commercial or financial 1 9 2 relationships that could be construed as a potential conflict of interest. TdS, AK and BP designed and supervised the study. SJS, EC, MU and SS carried out the field work 1 9 5 and initial microbiological characterisation of the isolates. SC, SD and EB carried out data analysis 1 9 6 and interpretation of the primary dataset. SM carried out genetic characterisation of isolates from LK 1 9 7 and UK. BP performed phylogenetic analyses. SM, TdS, AK and BP performed analysis of study 1 9 8 data. AK, BP, TdS and SM wrote the paper. GC, SP, CAA and LD provided data. All authors 1 9 9 contributed to and approved the final manuscript. We thank the Staphylococcal Reference Service team at PHE, Colindale for their assistance with 2 0 9 laboratory work. We also thank the microbiology laboratory staff at the Teaching Hospital 2 1 0 Anuradhapura for help with collection and initial characterisation of isolates. We are grateful to 2 , All isolates were mecA positive by PCR. egc = enterotoxin gene cluster (seg/i/m/n/o/u); SSTI = skin and soft tissue infection; * hospital onset cases of SSTI were surgical
